Drugs & medicalClass II

Central Admixture Pharmacy Services, Inc. recalls vasopressin 20 units added to 0.9% sodium chloride 100 mL*, 0.2 units/mL*, 100 mL per bag, Rx only, Central Admixture…

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Read the official notice →
Date
2023-05-31
Country
United States
Brand
Central Admixture Pharmacy Services
Product
vasopressin 20 units added to 0.9% sodium chloride 100 mL*, 0.2 units/mL*, 100 mL per bag, Rx only, Central Admixture Pharmacy Services,…
Classification
Class II
Units
Nationwide in the USA.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Central Admixture Pharmacy Services recalls

  1. 2026-07-01
  2. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc. recalls Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound…

    Incorrect product formulation: bag did not contain copper and famotidine per label.

    FDA · DrugCentral Admixture Pharmacy Services, Inc.MAOfficial notice →
  3. 2025-03-19
  4. US
    Drugs & medicalClass I

    Central Admixture Pharmacy Services, Inc. recalls PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy…

    Presence of Particulate Matter

    FDA · DrugCentral Admixture Pharmacy Services, Inc.Product was distributed nationwide within the United StatesOfficial notice →
  5. 2023-10-11
  6. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services Inc recalls fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San…

    Lack of assurance of sterility:

    FDA · DrugCentral Admixture Pharmacy Services IncNationwide in the USAOfficial notice →
  7. 2023-09-06
  8. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc. recalls EPINEPHrine added to dextrose 5%, 4mg/250ml (16 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc.,…

    Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

    FDA · DrugCentral Admixture Pharmacy Services, Inc.Nationwide in the USAOfficial notice →
  9. 2023-08-09
  10. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy…

    Lack of assurance of sterility: Lack of validation data for sanitization cycles

    FDA · DrugCentral Admixture Pharmacy Services IncNationwide in the USAOfficial notice →
  11. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc. recalls Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM, total volume = 250mL, IV Bag, Rx Only,…

    Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

    FDA · DrugCentral Admixture Pharmacy Services, Inc.Nationwide in the USAOfficial notice →
All 8 Central Admixture Pharmacy Services recalls →

Other drugs & medical recalls in the United States

  1. 2023-05-31
  2. US
    Drugs & medicalClass II

    Alpha Aromatics recalls FOAMING HAND SANITIZER, fresh mint scent, 62% alcohol, 1 Gallon / 3.78 Liters bottle, 290 Alpha Drive RIDC industrial Park, Pittsburgh, PA…

    CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

    FDA · DrugAlpha AromaticsProduct was distributed to one account in NC.Official notice →
  3. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03,…

    CGMP Deviations: recalling drug products following an FDA inspection.

    FDA · DrugAmerisource Health Services LLCNationwide USAOfficial notice →
  4. US
    Drugs & medicalClass III

    Amneal Pharmaceuticals of New York, LLC recalls Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue…

    Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number…

    FDA · DrugAmneal Pharmaceuticals of New York, LLCNationwide in the USA and PROfficial notice →
  5. 2023-05-24
  6. US
    Drugs & medicalClass II

    Stryker Sustainability Solutions recalls REF 5065, Kendall, Impad Rigid Sole Foot Cover, Regular Pair ,<12", Rx Only Non-Sterile

    Through complaint surveillance, it was identified that reprocessed Deep vein thrombosis (DVT) Compression Sleeves may be mislabeled and/or mispackaged.

    FDA · DeviceStryker Sustainability SolutionsUS: WA OUS: NoneOfficial notice →
  7. US
    Drugs & medicalClass II

    TELEFLEX LLC recalls Teleflex (manufacturer: Vascular SOLUTIONS) D-Stat Flowable Hemostat, REF 4000; for sealing residual oozing of tissue tracts of femoral…

    The product contains an expired diluent vial. If the impacted product is used, the sterility of the diluent component cannot be assured as it has passed beyond the studied shelf life of the product.

    FDA · DeviceTELEFLEX LLCUS NationwideOfficial notice →
  8. US
    Drugs & medicalClass II

    3M Company - Health Care Business recalls 3M Attest Steam Chemical Integrators, REF 1243B

    3M Attest Steam Chemical Integrators with dates of manufacture between November 6, 2022 and January 17, 2023 have an increased potential to leak ink during a sterilization cycle.

    FDA · Device3M Company - Health Care BusinessWorldwide distribution: US (nationwide) and OUS (foreign) countries of:…Official notice →
See all drugs & medical recalls →